Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight loss
Digital Health
Omada touts strong results of GLP-1 companion program
When coupled with wraparound lifestyle support, 63% of Omada members maintained or continued to lose weight 12 months after discontinuing GLP-1s.
Anastassia Gliadkovskaya
Sep 8, 2025 3:00pm
Fierce Pharma
Serena Williams discusses GLP-1 use as a Ro celebrity ambassador
Aug 22, 2025 5:39am
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
Aug 4, 2025 2:50pm
Payer Roundup—AOC slams CMMI model adding prior auth to Medicare
Jul 31, 2025 4:25pm
Hims & Hers to offer generic semaglutide drugs in Canada
Jul 11, 2025 3:30pm
WeightWatchers inks deal with Novo Nordisk to sell Wegovy
Jun 26, 2025 3:30pm